BioForce Nanosciences Holdings, Inc.,
a leader in systems integration at the micro- and nano-scales to create
products for the life sciences, is pleased to announce that European
distributor NanoAndMore GmbH has completed the sale of a Nano eNabler
System at the Italian Institute of Technology in Genova. The instrument
is scheduled to be installed in the Department of Neuroscience and
Brain Technologies (NBT), led by Professor Fabio Benfenati.
With this completion of their fourth sale in Continental
Europe, NanoAndMore GmbH CEO Peer Burshille reports that they continue
to encounter strong interest in the Nano eNabler benchtop molecular
printer. Mr. Burshille added, “I am encouraged by the
enthusiastic response we are receiving in Europe about the Nano eNabler
and I feel very confident that the current surge of interest is the
beginning of a trend. The addition of the new Cyto eNabler™
System to this line of products is, in my opinion, a wise move to
extend the capabilities of the technology and reach out to an ever
widening audience of customers.”
Kerry Frey, President and Chief Executive Officer of BioForce
Nanosciences, said, “We are very happy with
NanoAndMore’s success. They are a key component of our
worldwide network of distributors that is responsible for sales of our
products outside the US. This network operates in all major scientific
research markets and complements our US in-house sales force.”
BioForce recently announced the addition of the Cyto eNabler
System, an instrument custom tailored to the needs of the cell biology
market, to its product line. This new device offers a user friendly
entry into surface patterning for customers focused on stem cell
research, tissue engineering, and the development of live cell assays
to hasten the drug discovery process. The original Nano eNabler remains
the premier model, with capabilities that are ideal for developing new
biosensor concepts into useful diagnostic devices. Its nanoscale
precision and versatility to deposit virtually any biomaterial onto
sensor surfaces remains unmatched by any other technology.
BioForce Nanosciences Holdings, Inc., a leader in systems
integration at the micro- and nano-scales to create products for the
life sciences, is pleased to announce that European distributor
NanoAndMore GmbH has completed the sale of a Nano eNabler™
System at the Italian Institute of Technology in Genova. The instrument
is scheduled to be installed in the Department of Neuroscience and
Brain Technologies (NBT), led by Professor Fabio Benfenati.
With this completion of their fourth sale in Continental
Europe, NanoAndMore GmbH CEO Peer Burshille reports that they continue
to encounter strong interest in the Nano eNabler benchtop molecular
printer. Mr. Burshille added, “I am encouraged by the
enthusiastic response we are receiving in Europe about the Nano eNabler
and I feel very confident that the current surge of interest is the
beginning of a trend. The addition of the new Cyto eNabler™
System to this line of products is, in my opinion, a wise move to
extend the capabilities of the technology and reach out to an ever
widening audience of customers.”
Kerry Frey, President and Chief Executive Officer of BioForce
Nanosciences, said, “We are very happy with
NanoAndMore’s success. They are a key component of our
worldwide network of distributors that is responsible for sales of our
products outside the US. This network operates in all major scientific
research markets and complements our US in-house sales force.”
BioForce recently announced the addition of the Cyto eNabler
System, an instrument custom tailored to the needs of the cell biology
market, to its product line. This new device offers a user friendly
entry into surface patterning for customers focused on stem cell
research, tissue engineering, and the development of live cell assays
to hasten the drug discovery process. The original Nano eNabler remains
the premier model, with capabilities that are ideal for developing new
biosensor concepts into useful diagnostic devices. Its nanoscale
precision and versatility to deposit virtually any biomaterial onto
sensor surfaces remains unmatched by any other technology.
Posted 7th May 2008
